List view / Grid view
Addex Therapeutics has published new research showing that targeting the mGlu7 receptor with a negative allosteric modulator can disrupt fear memory reconsolidation, offering a potential new approach to treating anxiety and PTSD.
For the first time, researchers have demonstrated that flipping an epigenetic ‘switch’ in memory cells can directly control whether a memory is expressed or silenced, offering new insights into how memories are stored and potentially altered.
Scientists have developed a new computational model that reveals how the striosomal compartment of the brain’s striatum influences decision-making – which could lead to improved therapies for psychiatric disorders.
